Acute coronary syndrome care across Australia and New Zealand: the SNAPSHOT ACS study

Objectives: To characterise management of suspected acute coronary syndrome (ACS) in Australia and New Zealand, and to assess the application of recommended therapies according to published guidelines.

[1]  D. Chew,et al.  Measuring performance and outcomes of acute coronary syndromes management in Australia , 2012, The Medical journal of Australia.

[2]  I. Ranasinghe,et al.  Comparative Effectiveness of Population Interventions to Improve Access to Reperfusion for ST-Segment–Elevation Myocardial Infarction in Australia , 2012, Circulation. Cardiovascular quality and outcomes.

[3]  S. Gallagher,et al.  Diagnosis and management of patients with acute cardiac symptoms, troponin elevation and culprit-free angiograms , 2012, Heart.

[4]  S. Stewart,et al.  Application of Geographic Modeling Techniques to Quantify Spatial Access to Health Services Before and After an Acute Cardiac Event: The Cardiac Accessibility and Remoteness Index for Australia (ARIA) Project , 2012, Circulation.

[5]  S. Allen,et al.  From the Australian Commission on Safety and Quality in Health Care , 2011, The Medical journal of Australia.

[6]  K. Mahaffey,et al.  Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology ( ESC ) , 2012 .

[7]  P. Davidson,et al.  Lost in Translation: Health Resource Variability in the Achievement of Optimal Performance and Clinical Outcome , 2011, Circulation. Cardiovascular quality and outcomes.

[8]  H. White,et al.  2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006. , 2011, Heart, lung & circulation.

[9]  R. Califf,et al.  2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[10]  Judith S. Hochman,et al.  2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[11]  I. Crozier,et al.  High sensitivity troponin outperforms contemporary assays in predicting major adverse cardiac events up to two years in patients with chest pain , 2011, Annals of clinical biochemistry.

[12]  Eric Boerwinkle,et al.  Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study , 2011, Circulation.

[13]  H. Katus,et al.  Troponin elevation in coronary vs. non-coronary disease. , 2011, European heart journal.

[14]  H. White,et al.  ACS patients in New Zealand experience significant delays to access cardiac investigations and revascularisation treatment especially when admitted to non-interventional centres: results of the second comprehensive national audit of ACS patients. , 2010, The New Zealand medical journal.

[15]  H. White,et al.  Patients admitted with an acute coronary syndrome (ACS) in New Zealand in 2007: results of a second comprehensive nationwide audit and a comparison with the first audit from 2002. , 2010, The New Zealand medical journal.

[16]  Tobias Reichlin,et al.  Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.

[17]  H. Bueno,et al.  Patient Registries of Acute Coronary Syndrome: Assessing or Biasing the Clinical Real World Data? , 2009, Circulation. Cardiovascular quality and outcomes.

[18]  D. Chew,et al.  Acute coronary syndromes: consensus recommendations for translating knowledge into action , 2009, The Medical journal of Australia.

[19]  J. Amerena,et al.  Impact of acute and chronic risk factors on use of evidence-based treatments in patients in Australia with acute coronary syndromes , 2009, Heart.

[20]  I. Ranasinghe,et al.  Management and Outcomes of Patients with Acute Coronary Syndromes in Australia and New Zealand 2000–2007 , 2009 .

[21]  J. Amerena,et al.  Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registry , 2009, The Medical journal of Australia.

[22]  I. Scott,et al.  Discordance between level of risk and intensity of evidence‐based treatment in patients with acute coronary syndromes , 2007, The Medical journal of Australia.

[23]  A. Yan,et al.  Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes. , 2007, Archives of internal medicine.

[24]  F. Van de Werf,et al.  External validity of clinical trials in acute myocardial infarction. , 2007, Archives of internal medicine.

[25]  K. Eagle,et al.  Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) , 2006, BMJ : British Medical Journal.

[26]  A. Tonkin,et al.  Guidelines for the management of acute coronary syndromes 2006 , 2006, The Medical journal of Australia.

[27]  H. White,et al.  Acute Coronary Syndrome patients in New Zealand receive less invasive management when admitted to hospitals without invasive facilities. , 2004, The New Zealand medical journal.

[28]  A G Babiker,et al.  Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. , 1991, Statistics in medicine.